Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
bipolar psilocybin
Compass Pathways Psilocybin Trial Shows 80% Remission Rate in Bipolar II Disorder
December
7
,
2023